RB1 and cancer: In such scenarios, temporary inhibition of the RB1 function can potentially lead to the killing of cancer cells or an increase in their sensitivity to radio- or chemotherapeutic agents (Knudsen and Knudsen, 2008; Du and Searle, 2009).